Committee for Medicinal Products for Human Use
The Committee for Medicinal Products for Human Use (CHMP), formerly known as the Committee for Proprietary Medicinal Products (CPMP), is the European Medicines Agency's committee responsible for elaborating the agency's opinions on all issues regarding medicinal products for human use.
See also
[edit]References
[edit]- Enzmann, Harald; Schneider, C. (1 July 2008). "Die Rolle des Ausschusses für Humanarzneimittel (CHMP) bei der europäischen zentralen Zulassung". Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz ("The role of the Committee for Medicinal Products for Human Use (CHMP) in European centralised marketing authorisation") (in German). 51 (7): 731–739. doi:10.1007/s00103-008-0579-5. ISSN 1437-1588.
External links
[edit]- Committee for Medicinal Products for Human Use (CHMP)
- European Medicines Agency - Committee for Medicinal Products for Human Use (CHMP)
 | This article about a medical organization or association is a stub. You can help Wikipedia by expanding it. |
 | This article about the European Union is a stub. You can help Wikipedia by expanding it. |